These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
88 related items for PubMed ID: 9266826
1. Expression of dihydropyridine binding sites in renal epithelial cells. O'Neil RG, Reid JM, Williams RL, Karin NJ. Biochem Biophys Res Commun; 1997 Aug 08; 237(1):41-5. PubMed ID: 9266826 [Abstract] [Full Text] [Related]
2. Conserved Ca2+-antagonist-binding properties and putative folding structure of a recombinant high-affinity dihydropyridine-binding domain. Huber I, Wappl E, Herzog A, Mitterdorfer J, Glossmann H, Langer T, Striessnig J. Biochem J; 2000 May 01; 347 Pt 3(Pt 3):829-36. PubMed ID: 10769189 [Abstract] [Full Text] [Related]
6. Primary structure and functional expression of the cardiac dihydropyridine-sensitive calcium channel. Mikami A, Imoto K, Tanabe T, Niidome T, Mori Y, Takeshima H, Narumiya S, Numa S. Nature; 1989 Jul 20; 340(6230):230-3. PubMed ID: 2474130 [Abstract] [Full Text] [Related]
8. Fluorescent probing with felodipine of the dihydropyridine receptor and its interaction with the ryanodine receptor calcium release channel. Minarovic I, Mészáros LG. Biochem Biophys Res Commun; 1998 Mar 17; 244(2):519-24. PubMed ID: 9514900 [Abstract] [Full Text] [Related]
19. Key roles of Phe1112 and Ser1115 in the pore-forming IIIS5-S6 linker of L-type Ca2+ channel alpha1C subunit (CaV 1.2) in binding of dihydropyridines and action of Ca2+ channel agonists. Yamaguchi S, Zhorov BS, Yoshioka K, Nagao T, Ichijo H, Adachi-Akahane S. Mol Pharmacol; 2003 Aug 17; 64(2):235-48. PubMed ID: 12869628 [Abstract] [Full Text] [Related]